---

Suprascapular nerve block versus intraarticular corticosteroid in the treatment of periarthritis shoulder

Full Text PDF

---

Original Article

Author Details : Chinmoy Das, Partha Pratim Das, Ananta Hazarika, Avinish Kumar Singh*

Volume : 10, Issue : 1, Year : 2024

Article Page : 36-42

https://doi.org/10.18231/j.ijor.2024.008

Suggest article by email

Get Permission

Abstract

Background: Periarthritis shoulder, Frozen shoulder or adhesive capsulitis, presents as a significant clinical challenge with various therapeutic strategies being explored. This study aimed to compare the efficacy of suprascapular nerve block (SSNB) and intraarticular steroids, both adjunctive to physical therapy, in managing periarthritis shoulder.
Materials and Methods : We conducted a comparative study involving 50 patients diagnosed with frozen shoulder. Patients were segregated into two groups: one received SSNB (n=25), and the other received intraarticular steroids, followed by physical therapy in both groups.
Results: Patients undergoing SSNB showed a significant reduction in SPADI scores over a 12-week follow-up period, with a mean reduction of 64%. This group also recorded patient satisfaction scores of 8.5 ± 1.2 on a VAS (0-10) and a quality of life score of 85 ± 10 on the SF-36 scale. In contrast, the intraarticular steroids group, while also showing improvement, lagged behind the SSNB group in these metrics.
Conclusion: SSNB, when combined with physical therapy, emerges as a promising therapeutic strategy for periarthritis shoulder, demonstrating superior efficacy compared to intraarticular steroids in terms of pain reduction, function enhancement, and patient satisfaction. Further extensive studies are warranted to affirm these findings.
 

Keywords: Periarthritis shoulder, Suprascapular nerve block, Intraarticular steroids, SPADI score, physical therapy

How to cite : Das C, Das P P, Hazarika A, Singh A K, Suprascapular nerve block versus intraarticular corticosteroid in the treatment of periarthritis shoulder. IP Int J Orthop Rheumatol 2024;10(1):36-42

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 International License, which allows others to remix, and build upon the work, the licensor cannot revoke these freedoms as long as you follow the license terms.